Sacred Heart Medical Oncology Group is a clinical research site located in Pensacola, Florida, United States 32504.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Sacred Heart Medical Oncology Group has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.
Sponsors: Celgene, Galera Therapeutics, Inc., Amgen.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Sacred Heart Medical Oncology Group has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sacred Heart Medical Oncology Group has 6 clinical trials on record, with 1 currently active. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.
Yes — Sacred Heart Medical Oncology Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.